CME Credit: Medical Crossfire in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Offered by:
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Accreditation Council for Continuing Medical Education (ACCME):
1.5 AMA PRA Category 1 Credits™
Time to Complete: 90 minutes
Maximum Credits:
1.50 / AMA PRA Category 1 Credits™
1.50 / CNE Contact Hours
Activity Overview
Recent advances in prostate cancer screening have addressed the limitations of prostate-specific antigen (PSA) testing, which has a lack of specificity and a risk of overdiagnosis and overtreatment. New biomarker tests offer greater diagnostic accuracy by targeting specific biomarkers and potentially reducing unnecessary biopsies.
This educational activity aims to update health care professionals on advances in prostate cancer screening with the goal of improving prostate cancer risk assessment and decision-making and reducing unnecessary treatments. The Medical Crossfire format facilitates discussion in the context of evidence-based presentations, highlighting the current challenges and opportunities in the field and providing practical advice for implementing best practices.
Target Audience
This educational activity is directed toward urologists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in diagnosing patients for prostate cancer will be invited to participate as well.
Learning Objectives
Describe the inherent limitations of PSA screening in terms of specificity and prostate biopsies
Differentiate between adjunctive tests for prostate cancer assessment with respect to their clinical effectiveness in monitoring and active surveillance
Assess the latest clinical data regarding the role of adjunctive tests in the detection of high-grade prostate cancers
Incorporate adjunctive tests into clinical practice for prostate cancer risk assessment based upon the most up-to-date clinical evidence
Faculty
Jason Hafron, MD
Chief Medical Officer
Medical Director, Clinical Research
Michigan Institute of Urology, Solaris HealthProfessor of Urology
Oakland University William Beaumont School of Medicine
Aaron D. Berger, MD
Chief Medical Officer
Director, Clinical Research
Associated Urological Specialists, Solaris Health
Arpeet Shah, MD
Director, APP Program
Associated Urological Specialists, Solaris Health
Fill out form below to access The Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment:
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
DISCLAIMER: This information is provided for educational purposes only, and may or may not discuss investigational, unapproved, or off-label use of medical products. None of this information is intended to substitute for the independent judgment of a health care professional relative to diagnostic, treatment, or management of a specific patient’s medical condition. The opinions expressed are solely those of the faculty and do not reflect those of ClevelandDx. Please refer to clevelanddx.com for complete information.